Novo Nordisk Revenue

In the year 2024, Novo Nordisk had annual revenue of 290.40B DKK with 25.03% growth. Novo Nordisk had revenue of 85.68B in the quarter ending December 31, 2024, with 30.09% growth.

Revenue

290.40B

Revenue Growth

+25.03%

P/S Ratio

7.01

Revenue / Employee

3.78M

Employees

77,349

Market Cap

2,027.98B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	290.40B	58.14B	25.03%
Dec 31, 2023	232.26B	55.31B	31.26%
Dec 31, 2022	176.95B	36.15B	25.68%
Dec 31, 2021	140.80B	13.85B	10.91%
Dec 31, 2020	126.95B	4.93B	4.04%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Coloplast	27.45B
Genmab	21.53B
Demant	22.42B
Zealand Pharma	62.69M
Ambu A/S	5.65B
ALK-Abelló	5.54B
H. Lundbeck	22.00B
GN Store Nord	17.99B

Revenue Rankings

Novo Nordisk News

12 hours ago - Trump tariffs: these two European healthcare stocks face the highest US revenue exposure - Invezz
15 hours ago - Pharma tariff relief likely short-lived with sector-specific duties on the horizon - CNBC
17 hours ago - Novo Nordisk's head of commercial strategy Camilla Sylvest steps down - Seeking Alpha
18 hours ago - Novo Nordisk: Not As Bullish As Many - Seeking Alpha
19 hours ago - Novo Nordisk's head of commercial strategy steps down - Reuters
20 hours ago - Novo Nordisk announces changes in Executive Management - GlobeNewsWire
22 hours ago - Pharma stocks survive market rout on tariff exemption, but uncertainty continues - Reuters
1 day ago - FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine - Benzinga

More News